These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 30309831)

  • 1. Nanobodies as novel therapeutic agents in envenomation.
    Alirahimi E; Kazemi-Lomedasht F; Shahbazzadeh D; Habibi-Anbouhi M; Hosseininejad Chafi M; Sotoudeh N; Ghaderi H; Muyldermans S; Behdani M
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2955-2965. PubMed ID: 30309831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of protective agent against Hottentotta saulcyi venom using camelid single-domain antibody.
    Darvish M; Behdani M; Shokrgozar MA; Pooshang-Bagheri K; Shahbazzadeh D
    Mol Immunol; 2015 Dec; 68(2 Pt B):412-20. PubMed ID: 26468036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation.
    Yardehnavi N; Behdani M; Bagheri KP; Mahmoodzadeh A; Khanahmad H; Shahbazzadeh D; Habibi-Anbouhi M; Hassanzadeh Ghassabeh G; Muyldermans S
    FASEB J; 2014 Sep; 28(9):4004-14. PubMed ID: 24891523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing Dromedary-Derived Nanobodies Against BotI-Like Toxin From the Most Hazardous Scorpion Venom in the Middle East and North Africa Region.
    Ben Abderrazek R; Ksouri A; Idoudi F; Dhaouadi S; Hamdi E; Vincke C; Farah A; Benlasfar Z; Majdoub H; El Ayeb M; Muyldermans S; Bouhaouala-Zahar B
    Front Immunol; 2022; 13():863012. PubMed ID: 35514999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological aspects of scorpion toxins: current status and perspectives.
    Bouhaouala-Zahar B; Ben Abderrazek R; Hmila I; Abidi N; Muyldermans S; El Ayeb M
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):358-68. PubMed ID: 21756244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of recombinant scorpion antivenoms in E. coli: current state and perspectives.
    Alonso Villela SM; Kraïem-Ghezal H; Bouhaouala-Zahar B; Bideaux C; Aceves Lara CA; Fillaudeau L
    Appl Microbiol Biotechnol; 2023 Jul; 107(13):4133-4152. PubMed ID: 37199752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI'.
    Hmila I; Abdallah R BA; Saerens D; Benlasfar Z; Conrath K; Ayeb ME; Muyldermans S; Bouhaouala-Zahar B
    Mol Immunol; 2008 Aug; 45(14):3847-56. PubMed ID: 18614235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scorpion envenomation and serotherapy in Morocco.
    Ghalim N; El-Hafny B; Sebti F; Heikel J; Lazar N; Moustanir R; Benslimane A
    Am J Trop Med Hyg; 2000 Feb; 62(2):277-83. PubMed ID: 10813485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-clinical studies of toxin-specific nanobodies: evidence of in vivo efficacy to prevent fatal disturbances provoked by scorpion envenoming.
    Hmila I; Cosyns B; Tounsi H; Roosens B; Caveliers V; Abderrazek RB; Boubaker S; Muyldermans S; El Ayeb M; Bouhaouala-Zahar B; Lahoutte T
    Toxicol Appl Pharmacol; 2012 Oct; 264(2):222-31. PubMed ID: 22968189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Scorpion envenomation].
    Abroug F
    Tunis Med; 2001 May; 79(5):329-34. PubMed ID: 11515477
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-analysis of controlled studies on immunotherapy in severe scorpion envenomation: a commentary.
    Foëx BA
    Emerg Med J; 2011 Nov; 28(11):915-6. PubMed ID: 21670073
    [No Abstract]   [Full Text] [Related]  

  • 12. Camelid antivenom development and potential in vivo neutralization of Hottentotta saulcyi scorpion venom.
    Darvish M; Ebrahimi SA; Shahbazzadeh D; Bagheri KP; Behdani M; Shokrgozar MA
    Toxicon; 2016 Apr; 113():70-5. PubMed ID: 26809016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scorpion envenomation.
    Isbister GK; Bawaskar HS
    N Engl J Med; 2014 Jul; 371(5):457-63. PubMed ID: 25075837
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a new approach of immunotherapy against scorpion envenoming: Avian IgYs an alternative to equine IgGs.
    Sifi A; Adi-Bessalem S; Laraba-Djebari F
    Int Immunopharmacol; 2018 Aug; 61():256-265. PubMed ID: 29902709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of anti-scorpion venom serum over prazosin in the management of severe scorpion envenomation.
    Natu VS; Kamerkar SB; Geeta K; Vidya K; Natu V; Sane S; Kushte R; Thatte S; Uchil DA; Rege NN; Bapat RD
    J Postgrad Med; 2010; 56(4):275-80. PubMed ID: 20935398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments for Centruroides exilicauda envenomation.
    Rachesky IJ; Banner W; Dansky J; Tong T
    Am J Dis Child; 1984 Dec; 138(12):1136-9. PubMed ID: 6507396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of serotherapy in scorpion sting: a matched-pair study.
    Belghith M; Boussarsar M; Haguiga H; Besbes L; Elatrous S; Touzi N; Boujdaria R; Bchir A; Nouira S; Bouchoucha S; Abroug F
    J Toxicol Clin Toxicol; 1999; 37(1):51-7. PubMed ID: 10078160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antivenom for scorpion sting.
    Possani LD
    Lancet; 2000 Jan; 355(9197):67; author reply 67-8. PubMed ID: 10615911
    [No Abstract]   [Full Text] [Related]  

  • 19. Scorpion envenomation: state of the art.
    Abroug F; Ouanes-Besbes L; Tilouche N; Elatrous S
    Intensive Care Med; 2020 Mar; 46(3):401-410. PubMed ID: 32125457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the treatment for the cardiovascular manifestations of scorpion envenomation?
    Gueron M; Ovsyshcher I
    Toxicon; 1987; 25(2):121-30. PubMed ID: 3576632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.